본문으로 건너뛰기
← 뒤로

Comment on "Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast Cancer".

0/5 보강
Clinical breast cancer 📖 저널 OA 7.6% 2021: 0/2 OA 2022: 0/1 OA 2023: 0/1 OA 2024: 1/4 OA 2025: 0/5 OA 2026: 9/134 OA 2021~2026 2026 Vol.26(1) p. 3-4
Retraction 확인
출처

Dedeepya SD, Goel V, Desai NN

이 논문을 인용하기

↓ .bib ↓ .ris
APA Dedeepya SD, Goel V, Desai NN (2026). Comment on "Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast Cancer".. Clinical breast cancer, 26(1), 3-4. https://doi.org/10.1016/j.clbc.2025.10.012
MLA Dedeepya SD, et al.. "Comment on "Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast Cancer".." Clinical breast cancer, vol. 26, no. 1, 2026, pp. 3-4.
PMID 41260177 ↗

같은 제1저자의 인용 많은 논문 (5)